07Nov/13

Research and Markets: Therapy Class Overview : Rituximab Biosimilar … – Fort Mills Times

Research and Markets: Therapy Class Overview : Rituximab Biosimilar
Fort Mills Times
Approval of Inflectra/Remsima, the first biosimilar Monoclonal antibody (Mab) from Celltrion and Hospira in EU in 2013 is a trend setter! Inflectra is a biosimilar of Johnson & Johnson’s Remicade, which is approved for RA, Crohn’s disease and several

and more »

07Nov/13

Michael Carberry: From county journeyman to England opener – BBC Sport


BBC Sport

Michael Carberry: From county journeyman to England opener
BBC Sport
Having made his only Test appearance in Bangladesh three years ago, the Hampshire batsman was almost forced to quit cricket after becoming seriously ill with a blood clot on his lung in 2010. But after qualifying as an electrician – which has occupied
Warnie’s Pom protege firesSydney Morning Herald
The Ashes 2013-14: Michael Carberry’s feelgood story could resolve No 6 problemThe Independent
I owe my England chance to Shane Warne, says Michael CarberryZee News
Vancouver Desi
all 312 news articles »
07Nov/13

New study could help lead to prevention and treatment of heart failure in … – News-Medical.net

New study could help lead to prevention and treatment of heart failure in
News-Medical.net
​Researchers from the University of Texas Medical Branch at Galveston have discovered one of the pathogenic components of diabetes in the heart, as published in the Journal of Biological Chemistry. While both heart disease and diabetes are widely 

and more »